Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 66 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
651 15.4 months Recurrent or persistant ovarian or primary peritoneal cancer 4 Chemotherapy
Memorial Sloan-Kettering Center United States 12/2008
Treatment Details: Patients: This phase 2 study involved 78 women with ovarian cancer. They ranged in age from 30 to 89 years old. Most (85%) had received two previous chemotherapy treatments. Treatment:
 
652 15.4 months Metastatic colorectal cancer or advanced colorectal cancer 3 Chemotherapy
Queen Mary Hospital China 3/2008
Treatment Details: Patients: This phase II study involved 43 patients with advanced or metastatic colorectal carcinoma. The median age was 60, ranging from 33 to 75 years of age. The majority of patients (6
 
653 15.4 months metastatic breast cancer 4 Chemotherapy
Texas Oncology United States 8/2005
Treatment Details: Patients: This Phase III study involved 449 women with advanced breast cancer, of whom 394 were assessed. All patients had previously received an anthracycline-containing chemotherapy regi
 
654 15.4 months Melanoma 4 Immunotherapy
Gustave Roussy Comprehensive Cancer Center France 10/2013
Treatment Details: Patients: This phase 3 study involved 657 melanoma patients with a median age of 54 years; 54.3% were male. Treatment: Patients were given immunotherapy with a vaccine called GM2-KLH/QS
 
655 15.3 months Malignant pleural mesothelioma 5 Biologic therapy
Chemotherapy
Cliniche Humanitas Gavazzeni Italy 8/2013
Treatment Details: Patients: This phase 2 study involved 76 untreated malignant pleural mesothelioma patients. The median patient age was 67 years and 64% were male. Treatment: Patients were treated with
 
656 15.3 months NSCLC 5 Chemotherapy
Radiation
Wisconsin Institute for Medical Research United States 1/2012
Treatment Details: Patients: This phase III study involved non–small-cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 275 patients with a median age of 63 y
 
657 15.3 months NSCLC 5 Chemotherapy
Radiation
Wisconsin Institute for Medical Research United States 2/2012
Treatment Details: Patients: This phase III study involved non–small-cell lung cancer patients who were divided into two separate treatment groups. Group A had 275 patients with a median age of 63 years and
 
658 15.3 months Advanced breast cancer 4 Chemotherapy
Oslo University Hospital Norway 1/2012
Treatment Details: Patients: This phase II study involved women with advanced or metastatic breast cancer. The patients were divided into two separate treatment groups. Group A consisted of 19 patients with
 
659 15.3 months Hormone-refractory prostate cancer 4 Biologic therapy
University of Chicago United States 1/2004
Treatment Details: Patients: This Phase II trial involved 58 patients with hormone refractory prostate cancer. Median age was 72 years. All patients had received previous hormone therapy, 38 patients had rec
 
660 15.3 months Hormone-refractory prostate cancer 4 Biologic therapy
Hormone
University of California San Francisco United States 9/2004
Treatment Details: Patients: This Phase III trial involved a total of 260 patients with hormone refractory (androgen independent) prostate cancer. Patients were divided into two groups: Group 1 with 132 patie
 
Page 66 of 187  | Previous Page  | Next Page